tirzepatide for pregnancy safety data Long-Term Safety of Tirzepatide: What Research and Experts Reveal Between Bump and Blood Sugar:

Conclusions Though significant maternal or fetal complications were absent in this case despite tirzepatide exposure, large-scale prospective studies involving obese women planning pregnancy are warranted to evaluate the safety of this drug

Nausea, bloating, constipation, and fatigue are common, especially during the initial stages or when increasing the dose too rapidly

Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects

Obesity is a global health crisis affecting people of every background, and a drug seeking approval needs to demonstrate efficacy and safety across that spectrum

The company plans to submit its data for approval to the FDA and other regulators by mid-year

& Hansen, J